Dopaminergic and cholinergic lesions in progressive supranuclear palsy

Annals of Neurology

Volumn 18, Issue 5, 1985, Pages 523-529

  Ruberg, Merle ^a   Javoy‐Agid, France ^a   Hirsch, Etienne ^a   Scatton, Bernard ^b   Lheureux, Rémy ^b   Hauw, Jean‐Jacques ^a   Duyckaerts, Charles ^a   Gray, Françloise ^a   Morel‐Maroger, Ariel ^c   Rascol, André ^d   Serdaru, Michel ^a   Agid, Yves ^a  

^a Laboratoire de Neuropathologie Charles Foix   (France)

^b SANOFI   (France)

^c Service des Urgences Lits Porte (MB)   (France)

^d CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE; DOPAMINE; HOMOVANILLIC ACID; QUINUCLIDINYL BENZILATE H 3; RADIOISOTOPE; SPIPERONE H 3; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CORPUS STRIATUM; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HUMAN; HUMAN CELL; PARKINSON DISEASE; PEDUNCULAR ANSA; PHARMACOKINETICS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

AGED; BRAIN; BULBAR PALSY, PROGRESSIVE; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; DOPAMINE; FEMALE; FRONTAL LOBE; GLUTAMATE DECARBOXYLASE; HOMOVANILLIC ACID; HUMANS; MALE; NERVE DEGENERATION; PARKINSON DISEASE, SECONDARY; QUINUCLIDINYL BENZILATE; RECEPTORS, CHOLINERGIC; RECEPTORS, DOPAMINE; SPIPERONE; SUBSTANTIA INNOMINATA; SYNAPTIC TRANSMISSION;

EID: 0022198331     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410180503     Document Type: Article

References (34)

1. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat
2. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigrostriatal dopaminergic system in the rat
3. Striatal glutamate decarboxylase values, indicative of hospital where patient died
4. Subcortical dementia
5. The “subcortical dementia” of progressive supranuclear palsy
6. Brain dopamine and the syndromes of Parkinson and Huntington
7. 3H‐spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
8. Ncurotransmitter‐related enzymes and indices of hypoxia in senile dementia and other abiotrophies
9. Subcortico‐cortical cholinergic system is affected in Parkinson's disease
10. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum
11. The organization and some projections of cholinergic neurons of the mammalian forebrain
12. Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brain
13. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients
14. Is the mesocortical dopaminergic system involved in Parkinson disease?
15. Progressive supranuclear palsy
16. Progressive supranuclear palsy: clinicopathological and biochemical studies
17. Choline acetyltransferase‐containing neurons in rodent brain demonstrated by immunohistochemistry
18. Observations on the efficacy of L‐DOPA in progressive supranuclear palsy
19. Evidence for glutamic acid decarboxylase‐containing interneurons in the neostriatum
20. Problems in the diagnosis of progressive supranuclear palsy
21. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
22. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine
23. A postmortem study of the cholinergic and GABA systems in senile dementia
24. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia
25. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease
26. Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms
27. Progressive supranuclear palsy
28. Progressive supranuclear palsy
29. Distribution of striatal afferents from the mesencephalon in the cat
30. Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy
31. Basal forebrain neurons in the dementia of Parkinson disease
32. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
33. Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities